Genetic Technologies (GENE) Stock Highlights

0.8 | -27.93%

2024-07-13 05:33:26

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage womens health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the companys revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Statistics

Range Today

0.75 1.14

Volume Today 779.6K

Range 1 Year

1.05 4.75

Volume 1 Year 8.72M

Range 3 Year

1.05 20.45

Volume 3 Year 46.6M

Range 10 Year

1.05 220

Volume 10 Year 252.75M

Highlights

Market Capitalization 4.43M (micro)

Floating Shares 21.38M

Current Price 0.8

Price To Earnings -9.91

Price To Revenue 8.69

Price To Book 19.05

Earnings Per Share -0.11

Payout Ratio 0%

Performance

Latest -27.93%

1 Month -56.76%

3 Months -76.12%

6 Months -66.94%

1 Year -82.22%

3 Years -95.83%

5 Years -93.85%

10 Years -99.25%

Benchmarks

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

Total Rank

0 / 58

Free Cashflow

0 / 56

Performance 5 years

0 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.